Chiheal Biomed, guided by the principle of "Innovation Drives Development," extends its commitment to global clients, offering opportunities for the transfer and collaborative development of impactful Fast-Follow First-in-Class (FIC) innovative drugs. We take pride in delivering a comprehensive, "one-stop" service for innovative drug development, encompassing drug design, synthesis, pharmaceutical development, and clinical research services. Our platforms are designed to cater to the diverse needs of the industry, providing a seamless and integrated approach to ushering novel drugs from conception to realization.

Drug Design Platform：

Chiheal Biomed has an adept team in pharmaceutical design and development. Leveraging the power of Artificial Intelligence, we employ AI-assisted techniques to design potential organic molecules. Through the application of AI's deep learning neural network technology, we identify, categorize, extract, and analyze foundational research data. This enables us to precisely predict the "drug-target" interaction relationships, offering invaluable insights for the structural optimization of subsequent compounds. This assistive technology optimizes technical decisions and innovation, enhancing research and development efficiency while mitigating the risks and reducing the timelines associated with drug development.

Drug Synthesis Platform：

Chiheal Biomed house state-of-the-art facilities and an exceptionally experienced synthetic R&D team. Our expertise lies in the development, technical integration, and engineering validation of chiral drugs and chiral intermediates. This comprehensive approach fosters the engineering transformation of chiral drug technologies with independent intellectual property rights. We have successfully industrialized nearly ten chiral APIs, chiral intermediates, and chiral resolution agents. Multiple project applications have been completed, providing robust assurance for subsequent developments.

Pharmaceutical Development Platform：

Our platform consist of a sprawling 1,500-square-meter laboratory space, featuring specialized labs such as the Quality Standards Research Lab, Gas Chromatography Lab, Liquid Chromatography Lab, Spectroscopy Lab, Mass Spectrometry Lab, and Medicinal Molecular Activity Research Lab. Equipped with state-of-the-art instruments including multiple High-Performance Liquid Chromatography (HPLC), Liquid Chromatography-Mass Spectrometry (LC-MS), Gas Chromatography (GC), Circular Dichroism (CD) Spectrometer, Preparative Liquid Chromatography, Freeze Dryer, and more, our facilities meet the demanding requirements of preclinical drug development.

Our platform benefits from the guidance of renowned domestic experts, contributing their technical prowess to the platform's capabilities. We have successfully led numerous cutting-edge research projects, reflecting our wealth of experience in research and development.